Skip to main content
Article
Prospective Comparison of PET Imaging with PSMA-Targeted
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
  • Steven P Rowe
  • Xin Li
  • Bruce J Trock
  • Rudolf A Werner
  • Sarah Frey
  • Michael DiGianvittorio, Maine Medical Center
  • J Keith Bleiler
  • Diane K Reyes
  • Rehab Abdallah
  • Kenneth J Pienta
  • Michael A Gorin
  • Martin G Pomper
Document Type
Article
Publication Date
2-1-2020
Institution/Department
Radiology
Disciplines
MeSH Headings
Antigens, Surface, Bone Neoplasms, Fluorine Radioisotopes, Glutamate Carboxypeptidase II, Humans, Lysine, Male, Positron Emission Tomography Computed Tomography, Prospective Studies, Prostatic Neoplasms, Sodium Fluoride, Urea
Abstract

Bone metastases in prostate cancer (PCa) have important prognostic significance, and imaging modalities used for PCa staging should have high sensitivity for detecting such lesions. Prostate-specific membrane antigen (PSMA)-targeted PET radiotracers are promising new agents for imaging PCa. We undertook a head-to-head comparison of PSMA-targeted 2-(3-{1-carboxy-5-[(6-

Citation Information
Rowe SP, Li X, Trock BJ, et al. Prospective Comparison of PET Imaging with PSMA-Targeted 18F-DCFPyL Versus Na18F for Bone Lesion Detection in Patients with Metastatic Prostate Cancer. J Nucl Med. 2020;61(2):183-188. doi:10.2967/jnumed.119.227793